Skip to main content
Erschienen in: Journal of Nephrology 2/2016

01.04.2016 | Review

Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question

verfasst von: Mario Pacilio, Roberto Minutolo, Carlo Garofalo, Maria Elena Liberti, Giuseppe Conte, Luca De Nicola

Erschienen in: Journal of Nephrology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Appropriate timing of starting chronic dialysis in patients with advanced chronic kidney disease (CKD) under nephrology care still is undefined. We systematically reviewed the most recent studies that have compared outcomes of stage 5-CKD under conservative versus substitutive treatment. Eleven studies, most in elderly patients, were identified. Results indicate no advantage of dialysis over conservative management in terms of survival, hospitalization or quality of life. This information is integrated with a case report on a middle-aged CKD patient followed in our clinic who has remained for 15 years in stage 5 despite severe disease. The patient is a diabetic woman who underwent right nephrectomy in 1994 because of renal tuberculosis. In 1999, she commenced regular nephrology care in our clinic and, since 2000, when she was 53 years old, her estimated glomerular filtration rate (eGFR) has been ≤15 ml/min/1.73 m2. Over the last decade, despite, several episodes of acute kidney injury and placement of permanent percutaneous nephrostomy in 2001, renal function has remained remarkably stable, though severely impaired (eGFR 7.7–5.6 ml/min/1.73 m2). Our systematic analysis of the literature and this case report highlight the need for further studies, not limited exclusively to elderly patients, to verify the efficacy of non-dialysis treatment in stage 5-CKD patients. Meanwhile, nephrologists may consider that their intervention can safely prolong for several years the dialysis-free condition in ESRD independently of age.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Davison SN, Levin A, Moss AH et al (2015) Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care. Kidney Int 88(3):447–459 Davison SN, Levin A, Moss AH et al (2015) Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care. Kidney Int 88(3):447–459
3.
Zurück zum Zitat van de Luijtgaarden MW, Noordzij M, Tomson C et al (2012) Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis 60(6):940–948CrossRefPubMed van de Luijtgaarden MW, Noordzij M, Tomson C et al (2012) Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis 60(6):940–948CrossRefPubMed
4.
Zurück zum Zitat Tattersall J, Dekker F, Heimbürger O et al (2011) ERBP advisory board. When to start dialysis: updated guidance following publication of the initiating dialysis early and late (IDEAL) study. Nephrol Dial Transpl 26(7):2082–2086CrossRef Tattersall J, Dekker F, Heimbürger O et al (2011) ERBP advisory board. When to start dialysis: updated guidance following publication of the initiating dialysis early and late (IDEAL) study. Nephrol Dial Transpl 26(7):2082–2086CrossRef
5.
Zurück zum Zitat O’Connor NR, Kumar P (2012) Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 15(2):228–235CrossRefPubMedPubMedCentral O’Connor NR, Kumar P (2012) Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 15(2):228–235CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Brunori G, Viola BF, Parrinello G et al (2007) DODE study. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 49(5):569–580CrossRefPubMed Brunori G, Viola BF, Parrinello G et al (2007) DODE study. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 49(5):569–580CrossRefPubMed
7.
Zurück zum Zitat Cooper BA, Branley P, Bulfone L et al (2010) IDEAL study. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363(7):609–619 Cooper BA, Branley P, Bulfone L et al (2010) IDEAL study. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363(7):609–619
8.
Zurück zum Zitat Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE (2007) Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transpl 22(7):1955–1962CrossRef Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE (2007) Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transpl 22(7):1955–1962CrossRef
9.
Zurück zum Zitat Carson RC, Juszczak M, Davenport A, Burns A (2009) Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4(10):1611–1619CrossRefPubMedPubMedCentral Carson RC, Juszczak M, Davenport A, Burns A (2009) Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4(10):1611–1619CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K (2011) Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transpl 26(5):1608–1614CrossRef Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K (2011) Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transpl 26(5):1608–1614CrossRef
11.
Zurück zum Zitat Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K (2012) Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol 7(12):2002–2009CrossRefPubMedPubMedCentral Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K (2012) Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol 7(12):2002–2009CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Seow YY, Cheung YB, Qu LM, Yee AC (2013) Trajectory of quality of life for poor prognosis stage 5D chronic kidney disease with and without dialysis. Am J Nephrol 37(3):231–238CrossRefPubMed Seow YY, Cheung YB, Qu LM, Yee AC (2013) Trajectory of quality of life for poor prognosis stage 5D chronic kidney disease with and without dialysis. Am J Nephrol 37(3):231–238CrossRefPubMed
13.
Zurück zum Zitat Hussain JA, Mooney A, Russon L (2013) Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med 27(9):829–839CrossRefPubMed Hussain JA, Mooney A, Russon L (2013) Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med 27(9):829–839CrossRefPubMed
14.
Zurück zum Zitat Shum CK, Tam KF, Chak WL, Chan TC, Mak YF, Chau KF (2014) Outcomes in older adults with stage 5 chronic kidney disease: comparison of peritoneal dialysis and conservative management. J Gerontol A Biol Sci Med Sci 69(3):308–314CrossRefPubMed Shum CK, Tam KF, Chak WL, Chan TC, Mak YF, Chau KF (2014) Outcomes in older adults with stage 5 chronic kidney disease: comparison of peritoneal dialysis and conservative management. J Gerontol A Biol Sci Med Sci 69(3):308–314CrossRefPubMed
15.
Zurück zum Zitat Crews DC, Scialla JJ, Boulware LE et al (2014) Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis 63(5):806–815CrossRefPubMedPubMedCentral Crews DC, Scialla JJ, Boulware LE et al (2014) Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis 63(5):806–815CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Shih CJ, Chen YT, Ou SM, Yang WC, Kuo SC, Tarng DC, Taiwan Geriatric Kidney Disease Research (TGKD) Group (2014) The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study. BMC Med 12:169. doi:10.1186/s12916-014-0169-3 Shih CJ, Chen YT, Ou SM, Yang WC, Kuo SC, Tarng DC, Taiwan Geriatric Kidney Disease Research (TGKD) Group (2014) The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study. BMC Med 12:169. doi:10.​1186/​s12916-014-0169-3
17.
Zurück zum Zitat Rennke HG, Anderson S, Brenner BM (1989) Structural and functional correlations in the progression of renal disease. In: Tisher CC, Brenner BM (eds) Renal pathology. Lippincott, Philadelphia, p 43 Rennke HG, Anderson S, Brenner BM (1989) Structural and functional correlations in the progression of renal disease. In: Tisher CC, Brenner BM (eds) Renal pathology. Lippincott, Philadelphia, p 43
18.
19.
Zurück zum Zitat Maschio G, Oldrizzi L, Rugiu C (1991) Is there a “point of no return” in progressive renal disease? J Am Soc Nephrol 2(4):832–840PubMed Maschio G, Oldrizzi L, Rugiu C (1991) Is there a “point of no return” in progressive renal disease? J Am Soc Nephrol 2(4):832–840PubMed
20.
Zurück zum Zitat Rosansky SJ (2012) Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease. Am J Nephrol 36(1):1–10CrossRefPubMed Rosansky SJ (2012) Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease. Am J Nephrol 36(1):1–10CrossRefPubMed
21.
Zurück zum Zitat Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69(2):375–382CrossRefPubMed Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69(2):375–382CrossRefPubMed
22.
Zurück zum Zitat O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18(10):2758–2765CrossRefPubMed O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18(10):2758–2765CrossRefPubMed
23.
Zurück zum Zitat Al-Aly Z, Zeringue A, Fu J, Rauchman MI et al (2010) Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21(11):1961–1969CrossRefPubMedPubMedCentral Al-Aly Z, Zeringue A, Fu J, Rauchman MI et al (2010) Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21(11):1961–1969CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Perkins RM, Bucaloiu ID, Kirchner HL et al (2011) GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 6(8):1879–1886CrossRefPubMedPubMedCentral Perkins RM, Bucaloiu ID, Kirchner HL et al (2011) GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 6(8):1879–1886CrossRefPubMedPubMedCentral
25.
26.
Zurück zum Zitat De Nicola L, Minutolo R, Chiodini P et al (2012) The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int 82(4):482–488CrossRefPubMed De Nicola L, Minutolo R, Chiodini P et al (2012) The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int 82(4):482–488CrossRefPubMed
27.
Zurück zum Zitat Hunsicker LG, Adler S, Caggiula A et al (1997) Predictors of the progression of renal disease in the modification of diet in renal disease study. Kidney Int 51(6):1908–1919CrossRefPubMed Hunsicker LG, Adler S, Caggiula A et al (1997) Predictors of the progression of renal disease in the modification of diet in renal disease study. Kidney Int 51(6):1908–1919CrossRefPubMed
28.
Zurück zum Zitat Levin A, Djurdjie O, Beaulieu M, Er L (2008) Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 52(4):661–671CrossRefPubMed Levin A, Djurdjie O, Beaulieu M, Er L (2008) Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 52(4):661–671CrossRefPubMed
29.
Zurück zum Zitat Conway B, Webster A, Ramsay G et al (2009) Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 24(6):1930–1937CrossRefPubMed Conway B, Webster A, Ramsay G et al (2009) Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 24(6):1930–1937CrossRefPubMed
30.
Zurück zum Zitat Weis L, Metzger M, Haymann JP, Nephro Test Study Group et al (2013) Renal function can improve at any stage of chronic kidney disease. PLoS One 8(12):e81835 Weis L, Metzger M, Haymann JP, Nephro Test Study Group et al (2013) Renal function can improve at any stage of chronic kidney disease. PLoS One 8(12):e81835
31.
Zurück zum Zitat Jones C, Roderick P, Harris S, Rogerson M (2006) Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transpl 21(8):2133–2143CrossRef Jones C, Roderick P, Harris S, Rogerson M (2006) Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transpl 21(8):2133–2143CrossRef
32.
Zurück zum Zitat Tseng CL, Kern EF, Miller DR et al (2008) Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 168(1):55–62 Tseng CL, Kern EF, Miller DR et al (2008) Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 168(1):55–62
33.
Zurück zum Zitat Smart NA, Titus TT (2011) Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med 124(11):1073–1080CrossRefPubMed Smart NA, Titus TT (2011) Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med 124(11):1073–1080CrossRefPubMed
34.
Zurück zum Zitat De Nicola L, Provenzano M, Chiodini P et al (2015) Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care. PLoS One 10(5):e0127071CrossRefPubMedPubMedCentral De Nicola L, Provenzano M, Chiodini P et al (2015) Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care. PLoS One 10(5):e0127071CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Wong CF, McCarthy M, Howse ML, Williams PS (2007) Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Ren Fail 29(6):653–659CrossRefPubMed Wong CF, McCarthy M, Howse ML, Williams PS (2007) Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Ren Fail 29(6):653–659CrossRefPubMed
36.
Zurück zum Zitat De Biase V, Tobaldini O, Boaretti C et al (2008) Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. Nephrol Dial Transpl 23(4):1313–1317CrossRef De Biase V, Tobaldini O, Boaretti C et al (2008) Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. Nephrol Dial Transpl 23(4):1313–1317CrossRef
37.
Zurück zum Zitat Di Micco L, Torraca S, Pota A et al (2009) Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR—a study on safety, quality of life and economic impact. Nephrol Dial Transpl 24(11):3434–3440CrossRef Di Micco L, Torraca S, Pota A et al (2009) Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR—a study on safety, quality of life and economic impact. Nephrol Dial Transpl 24(11):3434–3440CrossRef
38.
Zurück zum Zitat Ellam T, El-Kossi M, Prasanth KC, El-Nahas M, Khwaja A (2009) Conservatively managed patients with stage 5 chronic kidney disease—outcomes from a single center experience. QJM 102(8):547–554CrossRefPubMed Ellam T, El-Kossi M, Prasanth KC, El-Nahas M, Khwaja A (2009) Conservatively managed patients with stage 5 chronic kidney disease—outcomes from a single center experience. QJM 102(8):547–554CrossRefPubMed
39.
Zurück zum Zitat Dattolo P, Michelassi S, Amidone M (2015) Structured clinical follow-up for CKD stage 5 may safely postpone dialysis. J Nephrol 28(4):463–469CrossRefPubMed Dattolo P, Michelassi S, Amidone M (2015) Structured clinical follow-up for CKD stage 5 may safely postpone dialysis. J Nephrol 28(4):463–469CrossRefPubMed
40.
Zurück zum Zitat Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361(16):1539–1547 Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361(16):1539–1547
41.
Zurück zum Zitat Conte G, Iavarone M, Santorelli V, De Nicola L (1997) Acute renal failure of unknown origin. Don’t forget renal tuberculosis. Nephrol Dial Transpl 12(6):1260–1261CrossRef Conte G, Iavarone M, Santorelli V, De Nicola L (1997) Acute renal failure of unknown origin. Don’t forget renal tuberculosis. Nephrol Dial Transpl 12(6):1260–1261CrossRef
42.
Zurück zum Zitat Evans M, van Stralen KJ, Schön S, ERA-EDTA Registry, Swedish Renal Registry Collaboration et al (2013) Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transpl 28(10):2518–2526 Evans M, van Stralen KJ, Schön S, ERA-EDTA Registry, Swedish Renal Registry Collaboration et al (2013) Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transpl 28(10):2518–2526
43.
Zurück zum Zitat Grootendorst DC, Michels WM, Richardson JD, NECOSAD Study Group et al (2011) The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transpl 26(6):1932–1937 Grootendorst DC, Michels WM, Richardson JD, NECOSAD Study Group et al (2011) The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transpl 26(6):1932–1937
44.
Zurück zum Zitat Lambers Heerspink HJ, Kröpelin TF, Hoekman J, de Zeeuw D, on behalf of the Reducing Albuminuria as Surrogate Endpoint (REASSURE) Consortium (2015) Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis. J Am Soc Nephrol 26(8):2055–2064 Lambers Heerspink HJ, Kröpelin TF, Hoekman J, de Zeeuw D, on behalf of the Reducing Albuminuria as Surrogate Endpoint (REASSURE) Consortium (2015) Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis. J Am Soc Nephrol 26(8):2055–2064
45.
Zurück zum Zitat Hansen HP, Christensen PK, Tauber-Lassen E, Klausen A, Jensen BR, Parving HH (1999) Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int 55(2):621–628CrossRefPubMed Hansen HP, Christensen PK, Tauber-Lassen E, Klausen A, Jensen BR, Parving HH (1999) Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int 55(2):621–628CrossRefPubMed
46.
Zurück zum Zitat Lambers Heerspink HJ, Holtkamp FA, Parving HH et al (2012) Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 82(3):330–337CrossRefPubMed Lambers Heerspink HJ, Holtkamp FA, Parving HH et al (2012) Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 82(3):330–337CrossRefPubMed
47.
48.
Zurück zum Zitat de Boer IH, Afkarian M, Rue TC, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group et al (2014) Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 25(10):2342–2350 de Boer IH, Afkarian M, Rue TC, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group et al (2014) Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 25(10):2342–2350
49.
Zurück zum Zitat Scalone L, Borghetti F, Brunori G et al (2010) Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients. Nephrol Dial Transpl 25(3):907–913CrossRef Scalone L, Borghetti F, Brunori G et al (2010) Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients. Nephrol Dial Transpl 25(3):907–913CrossRef
50.
Zurück zum Zitat Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B (2012) Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transpl 27(S3):73–80CrossRef Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B (2012) Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transpl 27(S3):73–80CrossRef
Metadaten
Titel
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question
verfasst von
Mario Pacilio
Roberto Minutolo
Carlo Garofalo
Maria Elena Liberti
Giuseppe Conte
Luca De Nicola
Publikationsdatum
01.04.2016
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 2/2016
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-015-0243-8

Weitere Artikel der Ausgabe 2/2016

Journal of Nephrology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.